Pseudophakes zystoides Makulaödem

Deutsche Ophthalmologische Gesellschaft (DOG); Retinologische Gesellschaft e.V. (RG); Berufsverband der Augenärzte Deutschlands e.V. (BVA)

doi:10.1055/a-2019-9748

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd 2023; 240(03): 316-326
DOI: 10.1055/a-2019-9748

Statement

Pseudophakes zystoides Makulaödem^[*]

Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands. Stand 22.10.2022Pseudophakic Cystoid Macular EdemaStatement of the German Society of Ophthalmology, the German Retina Society and the German Professional Association of Ophthalmologists. Status 22 October 2022 Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e.V. (RG), Berufsverband der Augenärzte Deutschlands e.V. (BVA)

Abstract

Full Text

References

Literatur
1 Bertelmann T, Witteborn M, Mennel S. Das pseudophakiebedingte zystoide Makulaodem. Klin Monbl Augenheilkd 2012; 229: 798-811
2 Guo S, Patel S, Baumrind B. et al. Management of pseudophakic cystoid macular edema. Surv Ophthalmol 2015; 60: 123-137
3 Han JV, Patel DV, Squirrell D. et al. Cystoid macular oedema following cataract surgery: a review. Clin Exp Ophthalmol 2019; 47: 346-356
4 Radeck V, Marker D, Prahs P. et al. Pseudophakes zystoides Makulaödem. Ophthalmologe 2020; 117: 579-590
5 Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol 1966; 76: 646-661
6 Chu CJ, Johnston RL, Buscombe C. et al. Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology 2016; 123: 316-323
7 Tu KL, Kaye SB, Sidaras G. et al. Effect of intraocular surgery and ketamine on aqueous and serum cytokines. Mol Vis 2007; 13: 1130-1137
8 Chung YR, Kim YH, Lee SY. et al. Insights into the pathogenesis of cystoid macular edema: leukostasis and related cytokines. Int J Ophthalmol 2019; 12: 1202-1208
9 McCafferty S, Harris A, Kew C. et al. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3 % versus placebo. BMC Ophthalmol 2017; 17: 16
10 Hollo G, Aung T, Cantor LB. et al. Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: mechanism, diagnosis, and management. Surv Ophthalmol 2020; 65: 496-512
11 Miyake K, Ota I, Ibaraki N. et al. Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol 2001; 119: 387-394
12 Taipale C, Holmstrom EJ, Ilveskoski L. et al. Incidence of pseudophakic cystoid macular edema in eyes with and without pupil expansion device. Acta Ophthalmol 2019; 97: 688-694
13 Blouin MC, Blouin J, Perreault S. et al. Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin. J Cataract Refract Surg 2007; 33: 1227-1234
14 Bradford JD, Wilkinson CP, Bradford jr. RH. Cystoid macular edema following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Retina 1988; 8: 161-164
15 Hunter AA, Modjtahedi SP, Long K. et al. Improving visual outcomes by preserving outer retina morphology in eyes with resolved pseudophakic cystoid macular edema. J Cataract Refract Surg 2014; 40: 626-631
16 Kessel L, Tendal B, Jorgensen KJ. et al. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology 2014; 121: 1915-1924
17 Lim BX, Lim CH, Lim DK. et al. Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery. Cochrane Database Syst Rev 2016; (11) CD6683
18 Wielders LH, Lambermont VA, Schouten JS. et al. Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: a systematic review and meta-analysis. Am J Ophthalmol 2015; 160: 968-981.e33
19 Wielders LHP, Schouten J, Winkens B. et al. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. J Cataract Refract Surg 2018; 44: 429-439
20 Donnenfeld ED, Perry HD, Wittpenn JR. et al. Preoperative ketorolac tromethamine 0.4 % in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg 2006; 32: 1474-1482
21 Yavas GF, Ozturk F, Kusbeci T. Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. J Cataract Refract Surg 2007; 33: 804-807
22 Grzybowski A, Sikorski BL, Ascaso FJ. et al. Pseudophakic cystoid macular edema: update 2016. Clin Interv Aging 2016; 11: 1221-1229
23 Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 2001; 108: 936-944
24 Miller KM, Oetting TA, Tweeten JP. et al. Cataract in the adult eye preferred practice pattern. Ophthalmology 2022; 129: P1-P126
25 NICE. Cataracts in adults. Im Internet (Stand: 28.08.2022): https://www.nice.org.uk/guidance/ng77
26 Wielders LHP, Schouten J, Winkens B. et al. Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED study report 2. J Cataract Refract Surg 2018; 44: 836-847
27 Schilling H, Pauleikhoff D, Schrenk M. et al. Therapie zystoider und diffuser Makulaodeme nach Uveitis und Katarakt-Chirurgie mit dem Carboanhydrase-Hemmer Acetazolamid (Diamox). Klin Monbl Augenheilkd 1993; 202: 206-211
28 Pepple KL, Nguyen MH, Pakzad-Vaezi K. et al. Response of inflammatory cystoid macular edema to treatment using oral acetazolamide. Retina 2019; 39: 948-955
29 Kuley B, Storey PP, Wibbelsman TD. et al. Resolution of pseudophakic cystoid macular edema: 2 mg Intravitreal triamcinolone acetonide versus 40 mg posterior sub-tenon triamcinolone acetonide. Curr Eye Res 2021; 46: 824-830
30 Orski M, Gawecki M. Current management options in Irvine-Gass syndrome: a systemized review. J Clin Med 2021;
31 Tariq F, Wang Y, Ma B. et al. Efficacy of intravitreal injection of filtered modified low-dose triamcinolone acetonide and ranibizumab on pseudophakic cystoid macular edema. Front Med (Lausanne) 2022; 9: 777549
32 Bellocq D, Pierre-Kahn V, Matonti F. et al. Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC-2 study. Br J Ophthalmol 2017; 101: 333-341
33 Spitzer MS, Ziemssen F, Yoeruek E. et al. Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg 2008; 34: 70-75
34 Staurenghi G, Lai TYY, Mitchell P. et al. Efficacy and safety of ranibizumab 0.5 mg for the treatment of macular edema resulting from uncommon causes: twelve-month findings from PROMETHEUS. Ophthalmology 2018; 125: 850-862

Pseudophakes zystoides Makulaödem[*]

Pseudophakes zystoides Makulaödem^[*]